1. Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers
   Melayshia McFadden et al, 2021, Cancers CrossRef
2. Potential of Zinc Oxide Nanoparticles as an Anticancer Agent: A Review
   Hemaroopini Subramaniam et al, 2022, Journal of Experimental Biology and Agricultural Sciences CrossRef
3. Interplay between paclitaxel, gap junctions, and kinases: unraveling mechanisms of action and resistance in cancer therapy
   Dong-Oh Moon, 2024, Molecular Biology Reports CrossRef
4. Indolyl-chalcone derivatives trigger apoptosis in cisplatin-resistant mesothelioma cells through aberrant tubulin polymerization and deregulation of microtubule-associated proteins
   Sophia Steinlein et al, 2023, Frontiers in Oncology CrossRef
5. A Comprehensive Review on Current Treatments and Challenges Involved in the Treatment of Ovarian Cancer
   Saika Saman et al, 2024, Current Cancer Drug Targets CrossRef
6. New trends in diagnosing and treating ovarian cancer using nanotechnology
   Juan Zhang et al, 2023, Frontiers in Bioengineering and Biotechnology CrossRef
7. Conventional to Nanoscale-Based Carrier Systems in the Management of Ovarian Cancer
   Sabya Sachi Das et al, 2022, Hormone Related Cancer Mechanistic and Nanomedicines CrossRef